103285-22-9

基本信息
5'-O-(4,4'-二甲氧基三苯基甲基)-2'-甲氧基尿苷
5'-DMT-2'-OMe-U
DMT-2'-O-METHYLURIDINE
5'-O-DMT-2'-O-methyluridine
5'-O-DMT-2'-O-methyl-D-uridine
5'-O-(DIMETHOXYTRITYL)-2'-O-METHYLURIDINE
5'-O-(4,4'-DIMETHOXYTRITYL)-2'-O-METHYLURIDINE
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-uridine
Uridine, 5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-O-Methyl-
1-((2R,3R,4R,5R)-5-((bis(4-Methoxyphenyl)(phenyl)Methoxy)Methyl)-4-hydroxy-3-Methoxytetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione
物理化學(xué)性質(zhì)
制備方法

109-88-6

173170-12-2

103285-22-9
甲醇鎂和N/A為原料合成1-((2R,3R,4R,5R)-5-((雙(4-甲氧基苯基)(苯基)甲氧基)甲基)-4-羥基-3-甲氧基四氫呋喃-2-基)嘧啶-2,4(1H,3H)-二酮的一般步驟如下:按照文獻(xiàn)方法,從尿苷經(jīng)兩步反應(yīng)制備5'-O-DMT-2,2'-O-脫水尿苷(6)。隨后,參照文獻(xiàn)報(bào)道的方法,將化合物6轉(zhuǎn)化為5'-O-DMT-2'-O-甲基尿苷。具體操作如下:首先,將鎂粉(0.5g)在甲醇(50mL)中于60℃加熱2小時(shí),蒸發(fā)過(guò)量甲醇并在真空下干燥,得到灰色粉末狀的甲醇鎂。將干燥的甲醇鎂(740mg,8.57mmol,6.00當(dāng)量)加入化合物6(750mg,1.42mmol,1.00當(dāng)量)在DMF(20mL)中的懸浮液中,將混合物加熱至100℃反應(yīng)2小時(shí),直至溶液澄清。反應(yīng)完成后,蒸發(fā)除去溶劑,將殘余物溶解于乙酸乙酯中。有機(jī)層依次用NaHCO3溶液和水洗滌,無(wú)水Na2SO4干燥后減壓濃縮。粗產(chǎn)物通過(guò)硅膠柱色譜法純化,洗脫劑為含2-4%甲醇的二氯甲烷溶液,得到化合物7(510mg,0.91mmol,收率64%)為白色固體。1H NMR(400MHz,CDCl3):δ(ppm)= 3.54-3.57(m,2H,H-C(5')),3.65(s,3H,2'-OCH3),3.79-3.80(m,7H,H-C(2'),DMT-OCH3),3.98-4.01(m,1H,H-C(4')),4.45-4.50(m,1H,H-C(3')),5.26(d,1H,J = 8.1 Hz,H-C(5)),5.97(s,1H,H-C(1')),6.82-6.86(m,4H,DMT-Har),7.24-7.39(m,9H,DMT-Har),8.03(d,1H,J = 8.1Hz,H-C(6));MS(ESI):m/z = 583.1 [M + Na]+。
參考文獻(xiàn):
[1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 20, p. 6171 - 6180
常見(jiàn)問(wèn)題列表
報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱(chēng) | CAS號(hào) | 包裝 | 價(jià)格 |
2025/05/22 | HY-W025438 | DMT保護(hù)性-2'-甲氧基尿苷 5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine | 103285-22-9 | 5 g | 363元 |
2025/05/22 | XW0210328522903 | 1-[(2R,3R,4R,5R)-5-[[雙(4-甲氧基苯基)-苯基甲氧基]甲基]-4-羥基-3-甲氧基氧代草烷-2-基]嘧啶-2,4-二酮 | 103285-22-9 | 1G | 79元 |
2025/05/22 | HY-W025438 | DMT保護(hù)性-2'-甲氧基尿苷 5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine | 103285-22-9 | 10 mM * 1 mLin DMSO | 399元 |